Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus

Clinical Therapeutics

Volumn 19, Issue 6, 1997, Pages 1408-1421

  Vignati, Louis ^a   Anderson Jr , James H ^a   Iversen, Philip W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Glycemic control; Hypoglycemia; IDDM; Insulin lispro; NIDDM

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; AGED; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIABETES MELLITUS; DRUG ABSORPTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031431551     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80014-8     Document Type: Article

References (19)

1. Brange J, Owens DR, Kang S, Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 1990;13:923-954.
2. American Diabetes Association. Clinical practice recommendations. Position statement: Insulin administration. Diabetes Care. 1995;18(Suppl 1):29-32.
3. Lean MEJ, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. BMJ. 1985;290:105-108.
4. Jorgensen LN, Nielsen FS. Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: A questionnaire study. Diabetologia. 1990;33:116A. Abstract 413.
5. Pullen RA, Lindsay DG, Wood SP, et al. Receptor-binding region of insulin. Nature. 1976;259:369-373.
6. DiMarchi RD, Mayer JP, Fan L, et al. Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In: Smith JA, Rivier JE, eds. Peptides - Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium. ESCOM; Leiden, Netherlands: 1992:26-28.
7. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(β28), Pro(β29)]-human insulin: A rapidly absorbed analogue of human insulin. Diabetes. 1994; 43:396-402.
8. Anderson JH, Brunelle RL, Koivisto VA, et al. Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group. Clin Ther. 1997;19:62-72.
9. Howey DC, Bowsher RR, Brunelle RL, et al. [Lys(β28), Pro(β29)]-human insulin: Effect of injection time on postprandial glycemia. Clin Pharmacol Ther. 1995;58: 459-469.
10. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics. 1972;28:577-584.
11. Taulbee JD. A note on the use of non-parametric methods in the statistical analysis of the two-period changeover design. Biometrics. 1982;38:1053-1055.
12. Nagelkerke NJD, Hart AAM, Oosting J. The two period binary response cross-over trial. Biomed J. 1986;28:863-869.
13. Service FJ, Nelson RL. Characteristics of glycemic stability. Diabetes Care. 1980;3: 58-62.
14. Pampanelli S, Torlone E, Ialli C, et al. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic β-cell function. Diabetes Care. 1995;18:1452-1459.
15. Anderson JH Jr, Brunelle RL, Keohane P, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Arch Intern Med. 1997;157:1249-1255.
16. Rowe R, Anderson JH, Gale E. A double-blind comparison of insulin lispro and regular insulin in patients on a multiple injection regimen. Diabetes. 1996;45(Suppl 2):71A. Abstract 253.
17. Bilo HJG, Heine RJ, Sikkenk AC, et al. Absorption kinetics and action profiles of intermediate acting human insulins. Diabetes Res. 1987;4:39-43.
18. Paisey RB, Macfarlane DG, Sherriff RJ, et al. The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetes. Diabetologia. 1980;19:31-34.
19. Anderson JH Jr, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes. 1997;46:265-270.